Preprint / Version 1

A Pilot, Prospective, Randomized-Controlled Study to Evaluate the Efficacy and Safety of Arsha Hita™ in the Treatment of Anal Fissures

Authors

  • Gopikrishna J General Surgery (Shalya Tantra), Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Hassan, IND
  • Rajmohan Seetharaman Pharmacology and Therapeutics, Seth Gordhandas Sunderdas Medical College and King Edward (VII) Memorial Hospital, Mumbai, IND
  • Kruttika Chitnis Pharmacology and Therapeutics, Seth Gordhandas Sunderdas Medical College and King Edward (VII) Memorial Hospital, Mumbai, IND
  • Mukesh Chawda Medical Services, Shree Dhootapapeshwar Limited, Mumbai, IND
  • Megha Nalawade Clinical Research, Shree Dhootapapeshwar Limited, Mumbai, IND
  • Sangam Narvekar Medical Services, Shree Dhootapapeshwar Limited, Mumbai, IND
  • Prasanna Rao General Surgery (Shalya Tantra), Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Hassan, IND
  • Suhas Shetty Psychiatry (Manas Rog), Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Hassan, IND
  • Sahanasheela R General Surgery (Shalya Tantra), Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Hassan, IND
  • Raakhi Tripathi Pharmacology and Therapeutics, Seth Gordhandas Sunderdas Medical College and King Edward (VII) Memorial Hospital, Mumbai, IND

Keywords:

vedic medicine, physician’s global impression, participant’s global impression, visual analogue scale, lidocaine plus nifedipine, assessor-blind study, parallel group, two-arm, active-controlled, ayurveda

Abstract

Introduction Anal fissures are tears in the anal canal that cause pain, bleeding, and spasms. They can be treated with non-operative options such as sitz baths, local anesthetics, topical nitrates, oral fiber, and calcium channel blockers, but some patients require surgery. Topical nitrates have side effects such as severe headaches, while topical calcium channel blockers can cause itching. There is a need to explore alternative treatments with fewer side effects. This proof-of-concept pilot study aimed to compare the efficacy and safety of a combination of Arsha Hita™ tablets and ointment (Shree Dhootapapeshwar Limited, Mumbai Maharastra, India) (test treatment) with a combination of lidocaine 1.5% w/w + nifedipine 0.3% w/w cream for local application and Isabgol powder (6 g) orally as an active comparator (standard treatment), which is the standard treatment of anal fissures as per the Association of Colon and Rectal Surgeons of India (ACRSI) guidelines. Methodology This study was a single-center, prospective, randomized-controlled study conducted in Karnataka, India. Participants were screened for anal fissures and randomized to receive either standard treatment (Group A) or test treatment (Group B) for 14 days, and were re-evaluated after two, four, and six weeks. The study assessed signs and symptoms related to anal fissures, such as pain post-defecation on Visual Analog Scale (VAS), bleeding per anus grading, wound healing grade, stool consistency, and stool frequency. Compliance, inter-current illness, and concomitant therapy were noted at each visit. The study used independent sample t-tests to compare variables at baseline and chi-square or Fisher's exact tests to compare the number/proportion of participants achieving primary and secondary endpoints. Mann-Whitney U test was used to compare median composite scores at baseline and Visit 4, and Friedman's two-way analysis of variance was used to compare median composite scores across the four visits (p < 0.05 was considered significant). Descriptive analysis was used to assess VAS, bleeding, and healing grades. Results The study included 53 participants with anal fissures, of which 25 out of 27 allocated in Group A (two drop-outs) received standard treatment, and all 26 allocated in Group B received Arsha Hita treatment. At the end of the study, 11 participants in Group B achieved a 90% reduction in composite scores compared to only three patients in Group A (p<0.05). Both groups showed improvement in pain on defecation, severity of bleeding, healing of anal fissure wound, and participant's and physician's global impression score. Group B had significantly better results in terms of VAS score, resolution of per-anal bleeding, and physician's global impression score (p<0.05). There were no adverse events in either group during the six-week treatment period. Conclusion The pilot study provides evidence that the combination of Arsha Hita tablets and Arsha Hita ointment may be more effective and safer for treating anal fissures than the standard treatment. The test treatment group experienced greater pain relief, complete resolution of per-anal bleeding, and better global impression scores than the standard treatment group. These findings suggest the need for further research through larger, randomized controlled trials to determine the efficacy and safety of Arsha Hita in treating anal fissures. Keywords: vedic medicine, physician’s global impression, participant’s global impression, visual analogue scale, lidocaine plus nifedipine, assessor-blind study, parallel group, two-arm, active-controlled, ayurveda

Downloads

Categories